Iambic Therapeutics, Inc. IPO Research Information

Iambic Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Iambic Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Iambic Therapeutics, Inc.	IAM - NASDAQ	$15.00-$17.00	$16.00	$16.15	9.375 million	10/15/2026
Underwriter(s): J.P. Morgan, Jefferies, BofA Securities, Citigroup
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2026-09-21 Terms Added 2026-10-08

Iambic Therapeutics, Inc. Quote & Chart - Click for current quote - IAM

About Iambic Therapeutics, Inc. (adapted from Iambic Therapeutics, Inc. prospectus):
They are a technology and clinical-stage life sciences company pursuing a fundamental shift in the biopharmaceutical industry.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "IAM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.